deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01032018

Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)

Comparison of Depression Interventions After Acute Coronary Syndrome (CODIACS)

Sponsor: Columbia University

Conditions Acute Coronary Syndrome Depression
Interventions Problem Solving Therapy Sertraline, citalopram, or bupropion Standard care
Updated 7 times since 2017 Last updated: Aug 15, 2017 Started: Jan 31, 2010 Primary completion: Jan 31, 2012 Completion: Jul 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Acute Coronary Syndrome and Depression and is currently completed. Columbia University leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotCompleted~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

▶ Show 2 earlier versions

  1. Oct 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

  2. Jan 2017 — Oct 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Columbia University
  • Emory University
  • National Heart, Lung, and Blood Institute (NHLBI)
  • University of North Carolina, Chapel Hill
  • University of Pennsylvania
  • Washington University School of Medicine
  • Yale University
Data source: Columbia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations